Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10494429 Compositions comprising purified anti-abeta monoclonal antibodies

Patent 10494429 was granted and assigned to Genentech on December, 2019 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

X. Christopher Yu0

Martin Vanderlaan0

Atia Naim0

Christopher A. Teske0

Date of Patent

December 3, 2019

0

Patent Application Number

159021410

Date Filed

February 22, 2018

0

Patent Citations Received

US Patent 12070502 Process for reducing subvisible particles in a pharmaceutical formulation

0

US Patent 11571636 Methods for quantitating individual antibodies from a mixture

US Patent 11680930 Methods and systems for chromatography data analysis

0

US Patent 11333642 Methods and systems for chromatography data analysis

US Patent 11369896 Methods for quantitating individual antibodies from a mixture

0

US Patent 11850535 Methods for quantitating individual antibodies from a mixture

0

US Patent 11884698 Systems and methods for preparing a polypeptide from a mixture

0

0

Patent Primary Examiner

0

Patent abstract

Purified recombinant polypeptides isolated from Chinese hamster ovary host cells, including antibodies, such as therapeutic antibodies, and methods of making and using such polypeptides are provided.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10494429 Compositions comprising purified anti-abeta monoclonal antibodies

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool